REGISTERED NUMBER: SC230534 (Scotland)

Strategic Report, Report of the Directors and

Financial Statements for the Year Ended 31 March 2025

for

Central Pharmacies (UK) Limited

Page

Company Information

1

Strategic Report

2

Report of the Directors

4

Report of the Independent Auditors

6

Income Statement

10

Other Comprehensive Income

11

Balance Sheet

12

Statement of Changes in Equity

13

Cash Flow Statement

14

Notes to the Cash Flow Statement

15

Notes to the Financial Statements

17

DIRECTORS:

P Aslam

G D C Mclaren

SECRETARY:

P Aslam

REGISTERED OFFICE:

Suite 4, Pavilion 3 St James Business Pa

Linwood Road

Paisley

PA3 3BB

REGISTERED NUMBER:

SC230534 (Scotland)

AUDITORS:

RA Audit Services Limited (Statutory Auditor)

2nd Floor

Grove House

55 Lowlands Road

Harrow

Middlesex

HA1 3AW

The directors present their strategic report for the year ended 31 March 2025.

REVIEW OF BUSINESS

Central Pharmacies (UK) Limited, has completed another successful year of trading.

The board monitors the Company's performance through the us of a variety of measurements, both financial and non-financial in order to maintain effective control over the business. The most important of these are known as key performance indicators (KPIs). The main financial KPIs that the Company monitors are turnover, gross profit, gross profit margin% and operating profit these are set out below.

The company's key performance indicators for the year ended 31 March 2025 are as follows:

YE 31.3.25

YE 31.3.24

£   s

£   s

Turnover

10,923

10,105

Gross profit

2,227

1,878

Gross profit margin

20.39%

18.58%

Profit before tax

1,346

1,086

Shareholders' equity

5,123

4,489

The company's key performance indicators were in line with expectations.

PRINCIPAL RISKS AND UNCERTAINTIES

The directors have set out below a number of key risks and uncertainties that could impact future performance:

Credit risk

The Company's principal financial assets are bank balances, trade and other receivables.

The Company's credit risk is primarily attributable to its trade receivables. The major proportion of the business receivables are from NHS. the amounts presented in the balance sheet are net of allowances for doubtful receivables.

Liquidity risk

Liquidity risk refers to the potential inability to meet financial obligations as they become due, which could adversely impact the company's ability to fund its operations and meet its short-term obligations. To effectively manage liquidity risk, Management maintains a robust liquidity management framework. This includes closely monitoring cash flow projections, maintaining adequate cash reserves, and regularly reviewing the company's financial position to identify potential liquidity challenges. The company has no debt obligations.

Regulatory compliance risk

The company is regulated by the General Pharmaceutical Council ('GPhC') and follows specific clinical and governance frameworks. The company's pharmacists are registered with the GPhC and maintain a close working relationship to mitigate the risk of non-compliance.

Currency risk

The majority of the company's purchases and sales are denominated in GBP, minimising currency risk.

Future prospects

The Company continues to improve its operating performance. The Company is well placed to grow revenue and operating profits and there are number of opportunities to expand.

ON BEHALF OF THE BOARD:

G D C Mclaren - Director

23 December 2025

The directors present their report with the financial statements of the company for the year ended 31 March 2025.

PRINCIPAL ACTIVITY

The principal activity of the company in the year under review was that of dispensing chemist in specialized stores.

DIVIDENDS

An interim dividend of £0.507 per share was paid on 30 March 2025, The directors recommend that no final dividend be paid.

The total distribution of dividends for the year ended 30 March 2025 will be £310,200 (2024: £188,000).

EVENTS SINCE THE END OF THE YEAR

Information relating to events since the end of the year is given in the notes to the financial statements.

DIRECTORS

The directors shown below have held office during the whole of the period from 1 April 2024 to the date of this report.

P Aslam

G D C Mclaren

STATEMENT OF DIRECTORS' RESPONSIBILITIES

The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-	select suitable accounting policies and then apply them consistently;

-	make judgements and accounting estimates that are reasonable and prudent;

-	prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS

So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he ought to have taken as a director in order to make himself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

AUDITORS

The auditors, RA Audit Services Limited (Statutory Auditor), will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:

G D C Mclaren - Director

23 December 2025

Opinion

We have audited the financial statements of Central Pharmacies (UK) Limited (the 'company') for the year ended 31 March 2025 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity, Cash Flow Statement and Notes to the Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

-	give a true and fair view of the state of the company's affairs as at 31 March 2025 and of its profit for the year then ended;

-	have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

-	have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

-	the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and

-	the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

-	adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

-	the financial statements are not in agreement with the accounting records and returns; or

-	certain disclosures of directors' remuneration specified by law are not made; or

-	we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the Statement of Directors' Responsibilities set out on page four, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditors' responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

Irregularities including fraud are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud.

Our approach to identifying and assessing the risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, was as follows:

The client partner ensured that the engagement team collectively had the appropriate competence, capabilities and skills to identify and recognise non-compliance with applicable laws and regulations.

1) We identified the laws and regulations applicable to the company through discussions with directors, key management personnel and from our commercial knowledge and experience.

2) We focused on specific laws and regulations which we considered may have a direct effect on financial statements or the operations of the company including Companies Act 2006, current taxation legislation, data protection, anti-bribery and money laundering, food safety, relevant medical bodies regulations, employment, and health and safety legislation.

3) We assessed the extent of compliance with the laws and regulations identified above through making enquiries of management.

4) Identified laws and regulations were communicated with the audit team regularly and the team remained alert to instances of non-compliance throughout the audit.

We assessed the susceptibility of the company's financial statements to material misstatement, including obtaining an understanding of how fraud might occur by;

1) Making enquiries of management as to where they considered there was susceptibility to fraud, their knowledge of actual suspected and alleged fraud and

2) Considering the internal controls in place to mitigate risks of fraud and non-compliance with laws and regulations.

To address the risk of fraud through management bias and override of controls, we:

1) Performed analytical procedures to identify any unusual and unexpected relationships,

2) Tested journal entries to identify unusual transactions,

3) Investigated the rationale behind significant or unusual transactions.

In response to the risk of irregularities and non-compliance with laws and regulations, we designed procedures which included,but were not limited to:

1) Agreeing financial statements disclosures to underlying supporting documentation.

2) Enquiring of management as to actual and potential litigation and claims and

3) Reviewing correspondence with HMRC, enquiring of management over health and safety.

There are inherent limitations in our audit procedures described above. Auditing standards also limit the audit procedures required to identifying non-compliance with laws and regulations to enquiry of the directors and other management and the inspection of regulatory and legal correspondence, if any.

Material misstatements that arise due to fraud can be harder to detect than those that arise from error as they may involve deliberate concealment or collusion.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

Use of our report

This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Abdul Hafeez ACA, FCCA (Senior Statutory Auditor)

for and on behalf of RA Audit Services Limited (Statutory Auditor)

2nd Floor

Grove House

55 Lowlands Road

Harrow

Middlesex

HA1 3AW

23 December 2025

TURNOVER

4

10,923,247

10,104,532

Cost of sales

8,695,899

8,226,903

GROSS PROFIT

2,227,348

1,877,629

Administrative expenses

819,439

730,551

1,407,909

1,147,078

Other operating income

6,000

6,000

OPERATING PROFIT

6

1,413,909

1,153,078

Interest receivable and similar income

63,196

27,810

1,477,105

1,180,888

Interest payable and similar expenses

7

131,018

94,477

PROFIT BEFORE TAXATION

1,346,087

1,086,411

Tax on profit

8

401,203

323,427

PROFIT FOR THE FINANCIAL YEAR

944,884

762,984

PROFIT FOR THE YEAR

944,884

762,984

OTHER COMPREHENSIVE INCOME

-

-

TOTAL COMPREHENSIVE INCOME FOR THE YEAR

944,884

762,984

FIXED ASSETS

Intangible assets

10

2,155,834

2,415,834

Tangible assets

11

683,302

551,973

Investments

12

100

100

2,839,236

2,967,907

CURRENT ASSETS

Stocks

13

418,705

438,895

Debtors

14

2,645,984

2,572,538

Cash at bank and in hand

2,836,293

2,424,025

5,900,982

5,435,458

CREDITORS

Amounts falling due within one year

15

1,898,615

1,987,204

NET CURRENT ASSETS

4,002,367

3,448,254

TOTAL ASSETS LESS CURRENT LIABILITIES

6,841,603

6,416,161

CREDITORS

Amounts falling due after more than one year

16

(1,625,058

)

(1,866,928

)

PROVISIONS FOR LIABILITIES

20

(93,226

)

(60,598

)

NET ASSETS

5,123,319

4,488,635

CAPITAL AND RESERVES

Called up share capital

21

355,000

355,000

Retained earnings

4,768,319

4,133,635

SHAREHOLDERS' FUNDS

5,123,319

4,488,635

The financial statements were approved by the Board of Directors and authorised for issue on 23 December 2025 and were signed on its behalf by:

G D C Mclaren - Director

Called up

share

Retained

Total

capital

earnings

equity

£

£

£

Balance at 1 April 2023

355,000

3,558,651

3,913,651

Changes in equity

Dividends

-

(188,000

)

(188,000

)

Total comprehensive income

-

762,984

762,984

Balance at 31 March 2024

355,000

4,133,635

4,488,635

Changes in equity

Dividends

-

(310,200

)

(310,200

)

Total comprehensive income

-

944,884

944,884

Balance at 31 March 2025

355,000

4,768,319

5,123,319

Cash flows from operating activities

Cash generated from operations

1

1,525,585

1,818,309

Interest paid

(122,754

)

(94,477

)

Interest element of hire purchase payments paid

(8,264

)

-

Tax paid

(299,050

)

(245,369

)

Net cash from operating activities

1,095,517

1,478,463

Cash flows from investing activities

Purchase of intangible fixed assets

-

(2,600,001

)

Purchase of tangible fixed assets

(220,772

)

(110,591

)

Interest received

63,196

27,810

Net cash from investing activities

(157,576

)

(2,682,782

)

Cash flows from financing activities

New loans in year

-

1,800,000

Loan repayments in year

(277,901

)

(224,260

)

New HP in year

103,295

76,000

Capital repayments in year

(40,867

)

-

Equity dividends paid

(310,200

)

(188,000

)

Net cash from financing activities

(525,673

)

1,463,740

Increase in cash and cash equivalents

412,268

259,421

Cash and cash equivalents at beginning of year

2

2,424,025

2,164,604

Cash and cash equivalents at end of year

2

2,836,293

2,424,025

1.	RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS

31.3.25

31.3.24

£

£

Profit before taxation

1,346,087

1,086,411

Depreciation charges

349,444

221,726

Finance costs

131,018

94,477

Finance income

(63,196

)

(27,810

)

1,763,353

1,374,804

Decrease/(increase) in stocks

20,190

(99,354

)

(Increase)/decrease in trade and other debtors

(73,446

)

230,330

(Decrease)/increase in trade and other creditors

(184,512

)

312,529

Cash generated from operations

1,525,585

1,818,309

2.	CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Year ended 31 March 2025

31.3.25

1.4.24

£

£

Cash and cash equivalents

2,836,293

2,424,025

Year ended 31 March 2024

31.3.24

1.4.23

£

£

Cash and cash equivalents

2,424,025

2,164,604

3.	ANALYSIS OF CHANGES IN NET FUNDS

At 1.4.24

Cash flow

At 31.3.25

£

£

£

Net cash

Cash at bank and in hand

2,424,025

412,268

2,836,293

2,424,025

412,268

2,836,293

Debt

Finance leases

(76,000

)

(62,428

)

(138,428

)

Debts falling due within 1 year

(269,872

)

-

(269,872

)

Debts falling due after 1 year

(1,795,301

)

277,901

(1,517,400

)

(2,141,173

)

215,473

(1,925,700

)

Total

282,852

627,741

910,593

1.	STATUTORY INFORMATION

Central Pharmacies (UK) Limited is a private company, limited by shares , registered in Scotland. The company's registered number and registered office address can be found on the Company Information page.

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from the dispensing of NHS prescription is recognised at transaction price and at the point the item is dispensed.

Goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 2024, is being amortised evenly over its estimated useful life of ten years.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.

Improvements to property

-

20% on reducing balance

Fixtures and fittings

-

20% on reducing balance

Motor vehicles

-

25% on reducing balance

Tangible fixed cost assets are measured at cost, net of depreciation and any impairment losses.

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Financial instruments

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments

Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they no longer at the discretion of the company.

Cash and cash equivalents

Cash at bank and in hand are basic financial assets and include cash in hand and deposits held at call with banks and bank overdraft. Bank overdrafts are shown within borrowings in current liabilities.

Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

Other operating income

Other operating income includes management fees receivable from overseas subsidiary and is recognised on receivable basis. It also incudes interest receivable from bank.

Going concern

After reviewing the forecasts and projections, which cover the 12-month period from the date of signing the financial statements, the directors have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. The company therefore continues to adopt the going concern basis in preparing its financial statements.

3.	CRITICAL ACCOUNTING JUDGEMENTS AND KEY SOURCES OF ESTIMATION UNCERTAINTY

In the application of the company's accounting policies, the directors are required to make judgments estimates and assumptions about the carrying amount of the assets and liabilities that are not readily apparent from other are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Key Sources of estimation uncertainty

The following judgements have had the most significant effect on amounts recognised in the financial statements.

Useful lives of intangible fixed assets

Intangible fixed assets consist of goodwill. The annual amortisation charge depends on estimated useful economic life of the asset. The directors regularly review the remaining useful life of these assets. Changes in asset's useful economic life can have a significant impact on amortisation charge for the period. Detail of the useful economic life is included in accounting policies.

Useful lives of tangible fixed assets

The costs of tangible fixed assets less their residual value are depreciated over their estimated useful economic lives which are estimated by the director. Changes in the expected level of usage and technological developments could impact on the useful economic lives of these assets; therefore, further depreciation charges could be revised.

4.

TURNOVER

The turnover and profit before taxation are attributable to the one principal activity of the company.

An analysis of turnover by class of business is given below:

31.3.25

31.3.24

£

£

Sales

10,923,247

10,104,532

10,923,247

10,104,532

An analysis of turnover by geographical market is given below:

31.3.25

31.3.24

£

£

United Kingdom

10,923,247

10,104,532

10,923,247

10,104,532

5.	EMPLOYEES AND DIRECTORS

31.3.25

31.3.24

£

£

Wages and salaries

1,475,679

1,296,190

Social security costs

109,797

92,322

Other pension costs

24,572

20,553

1,610,048

1,409,065

The average number of employees during the year was as follows:

31.3.25

31.3.24

Employees

76

66

31.3.25

31.3.24

£

£

Directors' remuneration

32,584

32,597

6.	OPERATING PROFIT

The operating profit is stated after charging:

31.3.25

31.3.24

£

£

Hire of plant and machinery

5,485

5,646

Other operating leases

83,202

72,127

Depreciation - owned assets

43,961

37,558

Depreciation - assets on hire purchase contracts

45,482

-

Goodwill amortisation

260,000

184,167

Auditors' remuneration

9,200

6,000